Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SomaLogic & Janssen Enter Agreement | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

SomaLogic & Janssen Enter Agreement

SomaLogic to analyze ~5000 proteins in each of at least 15,000 clinical samples from Janssen to identify & validate protein biomarkers for use to treat diseases

By: Betsy Louda

, Contract Pharma

SomaLogic, Inc. has entered into a collaborative agreement with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. 

 
Under the agreement terms, SomaLogic will analyze ~5000 proteins in each of at least 15,000 clinical samples from Janssen to identify and validate protein biomarkers for use by Janssen and SomaLogic in predicting, diagnosing, monitoring, and treating disease. Samples will come from patients suffering from different diseases for which Janssen is developing drugs, including but not limited to rheumatoid arthritis, inflammatory bowel disease, lupus, and cardiovascular and metabolic conditions.
 
“We are happy that the Janssen research teams are exploring the potential of our protein-measurement platform for their drug discovery and development efforts,” said Roy Smythe, SomaLogic chief executive officer. “We prefer this kind of ‘win-win’ collaboration, where each party shares data and expertise with the other in an effort to achieve the high value goal of more rapidly advancing healthcare.”
 
This agreement is part of the SomaLogic “SOMAscan® Access Program,” which was recently developed to give leading biopharmaceutical companies a way to use SomaLogic proprietary technology for their own drug discovery and development purposes, while supporting the SomaLogic mission to provide meaningful and actionable precision health information based on protein measurements across a wide range of diseases and conditions.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics